Field Trip Health Ltd. CEO Joseph Del Moral on Q1 2023 Results -- Earnings Call Transcript >FTRP
From Seeking Alpha: Field Trip Health Ltd. CEO Joseph Del Moral on Q1 2023 Results -- Earnings Call Transcript
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022
Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. ("Reunion" or
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal 1Q 2023 Fincl Results, Completed Corporate Reorganization on Aug 11
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal 1Q 2023 Fincl Results, Completed Corporate Reorganization on Aug 11
Field Trip Health Ltd. (FTRP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Field Trip Health Ltd. (FTRP - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2022. This widely
Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP) ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies,
Field Trip Health Ltd. Gets Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
06:16 AM EDT, 08/05/2022 (MT Newswires) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP), a global player in the development and delivery of psychedelic therapies, announced overnight Thursday that
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion Neuroscience Inc., remaining listed on the NASDAQ Stock
Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies
Globe Newswire 29-Jun-2022 4:37 PM- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.- Closing of the arrangement expected to
Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting
Approves spin-out of clinics business to Field Trip Health & Wellness Ltd., pending final court approval and additional customary closing conditionsTORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Fie
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022
TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announc
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET
- Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price NoticeTORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global le
Field Trip Health Ltd. (NASDAQ:FTRP) Short Interest Update
Field Trip Health Ltd. (NASDAQ:FTRP – Get Rating) was the target of a significant drop in short interest in May. As of May 31st, there was short interest totalling 421,200 shares, a drop of 19.4% fro
Field Trip Health Ltd. (NASDAQ:FTRP) Short Interest Up 43.3% in April
Field Trip Health Ltd. (NASDAQ:FTRP – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 310,800
Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022
Globe Newswire 29-Apr-2022 8:12 AMTORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
Globe Newswire 28-Apr-2022 6:19 PMTransaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychede
BRIEF-Field Trip Health Ltd Announces Intention To Separate The Field Trip Discovery And Field Trip Health Divisions Into Two Independent Public Companies
April 28 (Reuters) - Field Trip Health Ltd FTRP.TO :* . ANNOUNCES INTENTION TO SEPARATE THE FIELD TRIP DISCOVERY AND FIELD TRIP HEALTH DIVISIONS INTO TWO INDEPENDENT PUBLIC COMPANIES* SHAREHOLDERS OF
Field Trip Health Ltd. to Participate in Upcoming Investor Conferences
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announ
Field Trip Health Ltd. (NASDAQ:FTRP) Short Interest Down 37.4% in March
Field Trip Health Ltd. (NASDAQ:FTRP – Get Rating) saw a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 216,900 shares, a drop of 37.4% fr
Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
The Allowed Claims include Composition of FT-104 and Provides Protection until 2040TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a glob
Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference
TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announ